279 related articles for article (PubMed ID: 31976547)
1. Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.
Boeing T; de Souza P; Speca S; Somensi LB; Mariano LNB; Cury BJ; Ferreira Dos Anjos M; Quintão NLM; Dubuqoy L; Desreumax P; da Silva LM; de Andrade SF
Br J Pharmacol; 2020 May; 177(10):2393-2408. PubMed ID: 31976547
[TBL] [Abstract][Full Text] [Related]
2. The PPARγ-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells.
Boeing T; Speca S; de Souza P; Mena AM; Bertin B; Desreumax P; Mota da Silva L; Faloni de Andrade S; Dubuqoy L
Chem Biol Interact; 2022 Jan; 351():109712. PubMed ID: 34699766
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
[TBL] [Abstract][Full Text] [Related]
4. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
[TBL] [Abstract][Full Text] [Related]
5. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
[TBL] [Abstract][Full Text] [Related]
6. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
8. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
[TBL] [Abstract][Full Text] [Related]
9. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice.
Wang L; Wang R; Wei GY; Wang SM; Du GH
Biomed Pharmacother; 2020 Aug; 128():110262. PubMed ID: 32447214
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
[TBL] [Abstract][Full Text] [Related]
11. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents.
Atiq A; Shal B; Naveed M; Khan A; Ali J; Zeeshan S; Al-Sharari SD; Kim YS; Khan S
Eur J Pharmacol; 2019 Jan; 843():292-306. PubMed ID: 30529194
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
[TBL] [Abstract][Full Text] [Related]
13. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells.
Nishitani Y; Yamamoto K; Yoshida M; Azuma T; Kanazawa K; Hashimoto T; Mizuno M
Biofactors; 2013; 39(5):522-33. PubMed ID: 23460110
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.
Bastos RW; Pedroso SH; Vieira AT; Moreira LM; França CS; Cartelle CT; Arantes RM; Generoso SV; Cardoso VN; Neves MJ; Nicoli JR; Martins FS
Benef Microbes; 2016 Sep; 7(4):549-57. PubMed ID: 27133563
[TBL] [Abstract][Full Text] [Related]
15. Preventative effects of selenium-enriched
Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
[TBL] [Abstract][Full Text] [Related]
16. Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway.
Li Y; Shen L; Luo H
Int Immunopharmacol; 2016 Nov; 40():24-31. PubMed ID: 27569028
[TBL] [Abstract][Full Text] [Related]
17. Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice.
Nobre LMS; da Silva Lopes MH; Geraix J; Cajado AG; Silva JMR; Ribeiro LR; Freire RS; Cavalcante DIM; Wong DVT; Alves APNN; Lima-Júnior RCP
Life Sci; 2022 May; 296():120445. PubMed ID: 35245522
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil plays a crucial role in intestinal mucositis induced by antineoplastic chemotherapy.
Arifa RDN; Brito CB; de Paula TP; Lima RL; Menezes-Garcia Z; Cassini-Vieira P; Vilas Boas FA; Queiroz-Junior CM; da Silva JM; da Silva TA; Barcelos LS; Fagundes CT; Teixeira MM; Souza DG
Immunology; 2022 Mar; 165(3):355-368. PubMed ID: 34964126
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a single-dose irinotecan model of gastrointestinal mucositis.
Gibson RJ; Bowen JM; Alvarez E; Finnie J; Keefe DM
Chemotherapy; 2007; 53(5):360-9. PubMed ID: 17713326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
